Pacira BioSciences Presents Updated Three-Year Data On PCRX-201 Gene Therapy In Patients With Moderate-to-Severe Osteoarthritis Of The Knee, Showing Clinical Improvements For Up To 156 Weeks Following Single Administration
Author: Benzinga Newsdesk | October 28, 2025 07:13am